|
HS Code |
228037 |
| Cas Number | 4199-06-8 |
| Molecular Formula | C7H6BrNO2 |
| Molecular Weight | 216.03 |
| Appearance | Yellow solid |
| Melting Point | 53-57°C |
| Boiling Point | 272°C |
| Density | 1.67 g/cm³ |
| Solubility In Water | Insoluble |
| Flash Point | 132°C |
| Purity | Typically ≥98% |
| Smiles | CC1=CC(=C(C=C1)[N+](=O)[O-])Br |
| Inchi | InChI=1S/C7H6BrNO2/c1-5-2-3-6(8)7(4-5)9(10)11/h2-4H,1H3 |
| Refractive Index | 1.617 |
| Storage Conditions | Store at room temperature, keep container tightly closed |
| Synonyms | 2-Bromo-4-methyl-1-nitrobenzene; 4-Methyl-2-bromonitrobenzene |
As an accredited 2-Bromo-4-Methyl-1-Nitrobenzene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Bromo-4-Methyl-1-Nitrobenzene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Not every day does a chemical catch professional interest with the steady, practical value that 2-Bromo-4-Methyl-1-Nitrobenzene brings to the table. With its formula C7H6BrNO2 and a structure that combines a bromine and a methyl group on a nitrobenzene ring, this compound offers utility rooted in real-world needs. In my years working alongside bench chemists and project managers, one constant stands out: the demand for accessible, high-purity intermediates that don’t complicate scale-up or regulatory filings.
The batch consistency observed with 2-Bromo-4-Methyl-1-Nitrobenzene, often referred to by its registry number 6307-34-4, appeals to laboratories and manufacturing teams. This isn’t just about maintaining tight HPLC or GC specs—though those do matter—but about supporting predictable reaction profiles in scale-dependent workflows where every slight impurity matters downstream.
Most current lots of 2-Bromo-4-Methyl-1-Nitrobenzene provide a melting point near the expected 64-66°C range, aligning with established literature values. Analysts often confirm an assay above 98% after routine crystallization, and experienced users appreciate sharp physical properties, distinguishing this compound from related halonitrobenzenes with less stable profiles. You don’t have to dig through technical sheets to see that an off-color sample or an unexpected melting depression can create a ripple effect in multi-step synthesis: distorting yields, increasing purification work, or even shutting down a process until corrections happen.
Concerns about trace moisture, heavy metals, and unwanted isomers aren’t just hypothetical here. They shape day-to-day operations—from developing pharmaceuticals to creating new materials. Chemists benefit from clear, repeatable results, so the dryness and chemical cleanliness of each batch support more efficient project timelines and resource use.
Within the class of halonitrobenzenes, subtle differences create big impacts. Anyone who’s worked through aromatic substitutions knows the way a methyl group shifting from the 4-position to the 3-position upsets both the electronics and the reactivity profile. 2-Bromo-4-Methyl-1-Nitrobenzene’s specific substitution pattern makes it suitable for building blocks in pharmaceutical and agrochemical research. Bromine at the ortho position to nitro creates a handle for Suzuki or Buchwald couplings. Methyl group stabilization supports the control demanded in stepwise syntheses, where the nitro group’s activation can guide further transformations.
Other bromonitrobenzenes might seem similar but play very different roles in practice. Their reactivity window changes, their by-products vary, and even their storage can differ. You don’t see as much off-gassing or decomposition in sealed vials with 2-Bromo-4-Methyl-1-Nitrobenzene compared to some closely related analogues. These differences mean researchers can plan, budget, and scale with a little less worry on the variable side.
Sitting down with colleagues over coffee, talk often touches on what makes certain intermediates stick as “go-to” choices. In my own career, I’ve watched 2-Bromo-4-Methyl-1-Nitrobenzene serve as a core intermediate for regression studies in new drug development. Its structure allows for rapid functionalization. Whether exploring aryl amine derivatives or attaching heterocycles through Pd-catalyzed routes, the compound maintains its importance.
Small-to-medium chemical developers lean on its reliability when trialing pilot plant production of energetic materials, fungicides, or dye precursors. The sturdy nature of the molecule lends it longevity during storage and flexibility across methods like nucleophilic substitution or metal-catalyzed processes. Academic groups publish on its versatility across multiple journals, and patent searches reveal expansion into advanced polymers and fine chemical specialties.
Ctrl-F through any R&D group’s internal logs and you’ll see the same topics pop up: cost overruns, unpredictable delivery, purity failures. A single poorly characterized intermediate can undo weeks of work and dilute team morale. The reputation of 2-Bromo-4-Methyl-1-Nitrobenzene in overcoming these pain points owes much to producers who understand downstream customer needs. It’s easier to avoid regulatory headaches when hazardous impurities remain below reportable levels, not to mention the workflow improvements that come from products with reliable particle size and clean spectral profiles.
Speculative reports point to opportunities in greener chemistry approaches for this compound. In-house teams using continuous-flow reactors report less hazardous waste and safer containment of off-gassing compared to batch nitrations or brominations, lowering both environmental load and insurance costs. More suppliers now prioritize responsible waste handling and safer process intensification, which benefits operators, neighbors, and the end-user’s compliance teams alike.
Often, teams ask whether a simple swap to another nitrobenzene derivative could cut costs or enable new products. In truth, the unique mix of ortho-bromine and para-methyl groups in 2-Bromo-4-Methyl-1-Nitrobenzene produces a specific electronic bias on the aromatic ring. This means selectivity in cross-coupling reactions that other regioisomers cannot always provide. 3-Bromo forms, for instance, commonly create isomer mixtures that complicate chromatographic purification; 4-bromo versions shift activity in ring substitutions away from where medicinal chemists want it for SAR studies.
Anyone who’s run pilot-scale arylations knows the headaches poorly chosen intermediates can cause. Even simple properties like solubility and thermal stability become headaches when a molecule decomposes during workup or blocks a reactor with insoluble by-products. Technicians in the lab notice that 2-Bromo-4-Methyl-1-Nitrobenzene blends reasonable solubility in popular organic solvents with a low tendency to form glassy residues, making washes and extractions more manageable and losses less frequent.
Looking at the growing landscape of small-molecule innovation, the role that well-characterized intermediates play only becomes more central. With regulatory bodies scrutinizing supply chain integrity and end-to-end documentation, it pays to work with tried-and-trusted starting materials. Before high-throughput robotics and automated synthesis platforms took over the benches, researchers hand-selected every step, relying on intuition and experience. Today, computer models can predict optimal pathways, but the choice of intermediates like 2-Bromo-4-Methyl-1-Nitrobenzene isn’t just based on computation—there’s a deep well of trust built over years of publication and feedback.
In conversations with new recruits and veteran industry experts, a theme emerges. The pressure to innovate—faster, greener, and at lower cost—challenges every team member. At the same time, nobody wants to sacrifice reliability for novelty. The business case for compounds that let people try new routes, without backtracking for impurity profiles or stability issues, becomes clear. That’s the promise reflected over decades by this compound. Its documentation and prior art ease regulatory hurdles, provide robust validation data, and support internal training.
Years ago, a project team struggled with a persistent sidereaction during a multi-step synthesis of a key intermediate. Only after switching their core halonitrobenzene to 2-Bromo-4-Methyl-1-Nitrobenzene, sourced from a reputable vendor, did downstream conversions yield the expected purity and yield. That anecdote lines up with what QA teams see every season: products that combine electronic activation and steric properties at the right places cut waste and save on remediation steps. This can make a substantial difference to the bottom line, especially for projects with constrained budgets or tight deadlines.
Regulators and auditors don’t miss much these days. Every logbook, every spectrograph, every QC label must match. Trust in a supply of intermediates comes only after repeated success, which is why longtime users of this compound don’t swap it out lightly. Documenting the source, ensuring the integrity of each delivery, and keeping track of even the subtlest differences between lots can mean the difference between an approved process and a costly delay. Given its established record, the compound sits comfortably in the toolkit of compliance managers who value predictability alongside performance.
Databases reflect broad application of 2-Bromo-4-Methyl-1-Nitrobenzene in pharmaceutical, agricultural, and specialty chemical research. Its citation in reaction methodology papers and its use in combinatorial libraries illustrate why it matters in fast-paced innovation cycles. A recent analysis in a leading organic chemistry journal showed the compound as the starting point for several unique classes of substituted anilines, precursors for drugs under clinical investigation. Elsewhere, crop science teams cite its use as a safe and efficient intermediate for fungicide and growth regulator development.
What stands out is not only its adoption rate but also its reliability in the published work. Inventors rely on compounds they know will work at both screening and scale-up stages, reducing costly surprises. Whether targeting new ligands for catalysis or building out analogues for patent clusters, the structure provides both flexibility and confident returns. That breadth of application isn’t the norm for every halobenzene—and certainly not in the face of ever-tighter regulatory standards and performance reviews.
Anyone paying attention to industry trends knows how carefully modern companies now track green chemistry metrics. Reduced environmental impact matters just as much as reactivity or shelf-stability. Suppliers increasingly invest in manufacturing improvements that lower solvent waste, capture reaction by-products for recycling, and minimize energy consumption during production. Groups that routinely handle this compound point to safer storage and easier clean-up procedures, compared to some more volatile or less stable analogues. Simple shifts in handling, like adopting reusable containment vessels and promoting closed-loop rinsing cycles, further reduce footprints both within and outside the laboratory.
The roadmap ahead may include further advances in biocatalysis and solvent-free methodologies under continuous-flow conditions. While legacy processes set the stage, new developments with support from regulatory agencies and industrial R&D groups will likely ensure that the next generation of 2-Bromo-4-Methyl-1-Nitrobenzene matches today’s demand for both high performance and environmental protection.
Experienced team leads know that onboarding new chemists isn’t just about teaching reaction conditions—it involves guiding them to select intermediates wisely. The right choice, made early, can shape the whole direction of a research program. Investing in consistent, well-proven compounds frees up creative resources to tackle bigger challenges. It shifts lab time away from troubleshooting and toward real problem solving.
For young companies pushing boundaries in active pharmaceutical and materials discovery, the advantages of dependable intermediates form a bedrock. There’s little room for the unpredictability that comes from working with less-proven alternatives. Those heading operations for high-throughput screening platforms or flow chemical setups particularly appreciate consistency. Every minute saved from re-running reactions or adjusting protocols goes back into ideation and meaningful progress.
As the pace of discovery quickens and market competition grows fiercer, a handful of key intermediates see use not just because they’re readily available, but because experience, quality, and results bring certainty to ambitious projects. 2-Bromo-4-Methyl-1-Nitrobenzene has earned its place among these important tools. Its profile straddles the best aspects of stability, reactivity, and ease of handling, which means it gets invited into more project pipelines, gets trialed in new applications, and keeps its place at the workbench.
It’s not just the synthetic possibilities that drive its popularity. The workflow benefits—easier scaling, less process waste, better compliance outcomes—matter as much or more. For companies looking to stay lean or research groups managing slim budgets, every bit of dependability adds up. Familiarity leads to efficiency, and efficiency leads to better science, faster approvals, and stronger long-term relationships throughout the supply chain.
There’s never been a greater need for chemical intermediates that do exactly what’s expected, and nothing more. Groups large and small report upgrades in analytical monitoring, batch traceability, and certified impurity profiles, all driven by evolving industry standards. Some producers invest in smart factory automation, moving beyond human error in both measurement and documentation. Operations that once ran by hand now leverage digital tracking to provide even tighter control over purity and provenance. These advances pass through to users in the form of shorter lead times, better batch matching, and more transparent sourcing.
The prospect of further improvements looms large. New separation methods promise greater purity, and next-generation synthetic protocols suggest safer, less energy-intensive production. Industry roundtables regularly feature user feedback, and the result is a dialogue that keeps the compound’s value moving upward. It’s less a story of dramatic transformation and more a reminder of continuous, incremental progress that makes tangible differences for everyone involved.
At heart, 2-Bromo-4-Methyl-1-Nitrobenzene serves as both a technical asset and a symbol of what works in the bustling world of organic synthesis. Its status comes not from marketing but from the lived experience of scientists, engineers, and managers who have watched it deliver year after year. Users return because they trust the record—it’s easier to innovate, easier to scale, and easier to document with the right building blocks in place. That trust, now more than ever, counts for as much as any innovation or technical advance.
The future will demand even more from intermediates: lower cost, greener footprints, flawless documentation, faster adaptation. 2-Bromo-4-Methyl-1-Nitrobenzene offers a rare combination—proven performance and the flexibility to meet evolving industry needs. As research accelerates, its presence in both new methods and established pipelines only grows, anchoring supplies and supporting the teams that turn potential into product.